NASDAQ: KPRX
Kiora Pharmaceuticals Inc Stock Ownership - Who owns Kiora Pharmaceuticals?

Insider buying vs selling

Have Kiora Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric Joseph DanielsChief Development Officer2026-03-03238$2.02
$480.76Sell
Brian M. StremPresident and CEO2026-03-03238$2.02
$480.76Sell

1 of 1

KPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KPRX insiders and whales buy or sell their stock.

KPRX Shareholders

What type of owners hold Kiora Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC203.33%7,478,202$15.26MInsider
Innoven Partenaires Sa Ipsa39.71%1,460,479$2.98MInsider
Ventech Capital II38.93%1,431,814$2.92MInsider
Private Equity Natixis18.33%674,205$1.38MInsider
Barbara Wirostko12.61%463,808$946.17kInsider
Michael Garanzini5.34%196,250$400.35kInsider
Adar1 Capital Management LLC4.57%167,941$342.60kInstitution
Stonepine Capital Management LLC3.57%131,144$267.53kInstitution
Drw Securities LLC3.00%110,282$224.98kInstitution
Nantahala Capital Management LLC2.89%106,156$216.56kInstitution

1 of 3

KPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KPRX5.45%94.55%Net SellingNet Selling
RNAZ0.11%99.89%
CLGN12.04%2.95%
APRE2.77%97.23%Net BuyingNet Buying
PHGE0.96%99.04%Net SellingNet Selling

Kiora Pharmaceuticals Stock Ownership FAQ

Who owns Kiora Pharmaceuticals?

Kiora Pharmaceuticals (NASDAQ: KPRX) is owned by 17.89% institutional shareholders, 310.16% Kiora Pharmaceuticals insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Kiora Pharmaceuticals shareholder, owning 7.48M shares representing 189.29% of the company. Armistice Capital LLC's Kiora Pharmaceuticals shares are currently valued at $14.73M.

If you're new to stock investing, here's how to buy Kiora Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.